170 related articles for article (PubMed ID: 37232276)
1. Newly diagnosed non-small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis.
Zhu M; Yi J; Su Y; Zhang Y; Gao Y; Xu X; Zhang S; Zhang Y; Huang K
Thorac Cancer; 2023 Jul; 14(19):1874-1882. PubMed ID: 37232276
[TBL] [Abstract][Full Text] [Related]
2. Automated CT quantification of interstitial lung abnormality and interstitial lung disease according to the Fleischner Society in patients with resectable lung cancer: prognostic significance.
Ahn Y; Lee SM; Choi S; Lee JS; Choe J; Do KH; Seo JB
Eur Radiol; 2023 Nov; 33(11):8251-8262. PubMed ID: 37266656
[TBL] [Abstract][Full Text] [Related]
3. Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study.
Hida T; Hata A; Lu J; Valtchinov VI; Hino T; Nishino M; Honda H; Tomiyama N; Christiani DC; Hatabu H
Cancer Imaging; 2021 Jan; 21(1):14. PubMed ID: 33468255
[TBL] [Abstract][Full Text] [Related]
4. Clinical implication of interstitial lung abnormality in elderly patients with early-stage non-small cell lung cancer.
Cho SW; Jeong WG; Lee JE; Oh IJ; Song SY; Park HM; Lee HJ; Kim YH
Thorac Cancer; 2022 Apr; 13(7):977-985. PubMed ID: 35150070
[TBL] [Abstract][Full Text] [Related]
5. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer.
Nakanishi Y; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Tsutani Y; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
Respir Investig; 2019 Sep; 57(5):451-459. PubMed ID: 31248832
[TBL] [Abstract][Full Text] [Related]
6. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes.
Ito M; Katano T; Okada H; Sakuragi A; Minami Y; Abe S; Adachi S; Oshima Y; Ohashi W; Kubo A; Fukui T; Ito S; Suzuki K
Radiol Oncol; 2023 Jun; 57(2):229-238. PubMed ID: 37078697
[TBL] [Abstract][Full Text] [Related]
7. Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome.
Araki T; Dahlberg SE; Hida T; Lydon CA; Rabin MS; Hatabu H; Johnson BE; Nishino M
Eur J Radiol Open; 2019; 6():128-131. PubMed ID: 30984804
[TBL] [Abstract][Full Text] [Related]
8. Interstitial lung abnormalities in treatment-naïve advanced non-small-cell lung cancer patients are associated with shorter survival.
Nishino M; Cardarella S; Dahlberg SE; Araki T; Lydon C; Jackman DM; Rabin MS; Hatabu H; Johnson BE
Eur J Radiol; 2015 May; 84(5):998-1004. PubMed ID: 25726730
[TBL] [Abstract][Full Text] [Related]
9. Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis.
Patel AS; Miller E; Regis SM; Hunninghake GM; Price LL; Gawlik M; McKee AB; Rieger-Christ KM; Pinto-Plata V; Liesching TN; Wald C; Hashim J; McKee BJ; Gazourian L
Respir Res; 2023 Feb; 24(1):49. PubMed ID: 36782326
[TBL] [Abstract][Full Text] [Related]
10. Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival.
Chae KJ; Chung MJ; Jin GY; Song YJ; An AR; Choi H; Goo JM
Eur Radiol; 2022 Apr; 32(4):2713-2723. PubMed ID: 34984519
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement.
Kadoch M; Kitich A; Alqalyoobi S; Lafond E; Foster E; Juarez M; Mendez C; Smith TW; Wong G; Boyd WD; Southard J; Oldham JM
Respir Med; 2018 Apr; 137():55-60. PubMed ID: 29605213
[TBL] [Abstract][Full Text] [Related]
13. Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients.
Jeong WG; Kim YH; Ahn SJ; Jeong JU; Lee BC; Cho IJ; Kim YH
Anticancer Res; 2023 Apr; 43(4):1797-1807. PubMed ID: 36974810
[TBL] [Abstract][Full Text] [Related]
14. Automated CT quantification of interstitial lung abnormality in patients with resectable stage I non-small cell lung cancer: Prognostic significance.
Chung JH; Park JM; Kim DH
Thorac Cancer; 2024 Apr; ():. PubMed ID: 38682806
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over 2 years of surveillance.
Mackintosh JA; Marshall HM; Slaughter R; Reddy T; Yang IA; Bowman RV; Fong KM
Intern Med J; 2019 Jul; 49(7):843-849. PubMed ID: 30350396
[TBL] [Abstract][Full Text] [Related]
16. Bronchial epithelial gene expression and interstitial lung abnormalities.
Menon AA; Lee M; Ke X; Putman RK; Hino T; Rose JA; Duan F; Ash SY; Cho MH; O'Connor GT; Dupuis J; Hatabu H; Lenburg ME; Billatos ES; Hunninghake GM;
Respir Res; 2023 Oct; 24(1):245. PubMed ID: 37817229
[TBL] [Abstract][Full Text] [Related]
17. Spectrum of Pulmonary Fibrosis from Interstitial Lung Abnormality to Usual Interstitial Pneumonia: Importance of Identification and Quantification of Traction Bronchiectasis in Patient Management.
Hino T; Lee KS; Han J; Hata A; Ishigami K; Hatabu H
Korean J Radiol; 2021 May; 22(5):811-828. PubMed ID: 33543848
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic pulmonary fibrosis in patients with early-stage non-small-cell lung cancer after surgical resection.
Nezka H; Igor P; Izidor K
Radiol Oncol; 2019 Sep; 53(3):357-361. PubMed ID: 31553706
[TBL] [Abstract][Full Text] [Related]
19. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.
Putman RK; Gudmundsson G; Axelsson GT; Hida T; Honda O; Araki T; Yanagawa M; Nishino M; Miller ER; Eiriksdottir G; Gudmundsson EF; Tomiyama N; Honda H; Rosas IO; Washko GR; Cho MH; Schwartz DA; Gudnason V; Hatabu H; Hunninghake GM
Am J Respir Crit Care Med; 2019 Jul; 200(2):175-183. PubMed ID: 30673508
[No Abstract] [Full Text] [Related]
20. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
